Silicon DNA Synthesis

by Twist BioscienceUS

High-throughput DNA synthesis on silicon microfluidic chips. Customers order genes and oligonucleotide pools.

ScalingStage 5 of 5

Market leader in synthetic DNA. FY2026 guidance: $194–199M revenue, 15–18% growth.

Updated 3 Aug 2026Checked 10 Oct0 updates this week

Milestones

Next · Full-year FY2026 results
  1. Company founded2013Complete.
  2. Twist Bioscience IPO2018Complete.
  3. Q1 FY2026: DNA Synthesis revenue $51.1M, up 27% YoY2026Complete.
  4. Q3 FY2026: DNA Synthesis revenue $56.6M, up 39% YoY30 Jun 2026Complete.

Most important, last 3 months

Upcoming

  1. Nov 2026Full-year FY2026 resultsin about 3 weeks (next)
Primer